Clinical Significance of CD109 Expression and Methylation Patterns in Acute Myeloid Leukemia
Our results suggest that CD109 exhibits elevated expression and hypomethylation in AML, with its expression being regulated by methylation of its promoter region. Furthermore, CD109 could serve as a prognostic indicator as well as a monitoring tool for the therapeutic outcome in AML.
Authors
- Zi‐jun Xu (ORCID: https://orcid.org/0000-0002-5051-6799)
- Ming‐qiang Chu
- Jun Qian (ORCID: https://orcid.org/0000-0002-2649-8121)
- Shuangxi Liu (ORCID: https://orcid.org/0000-0002-1422-1096)
- Tingting Du (ORCID: https://orcid.org/0000-0002-1350-6778)
- Wei Zhao (ORCID: https://orcid.org/0009-0008-9167-4313)
- Jiang Lin (ORCID: https://orcid.org/0000-0002-4704-9157)
- Minjie Zhang (ORCID: https://orcid.org/0000-0001-8561-0729)
- Xiang-mei Wen (ORCID: https://orcid.org/0000-0003-0413-7912)
- Jing-dong Zhou (ORCID: https://orcid.org/0000-0002-7187-179X)
Publication Details
- Journal
- Clinical Laboratory
- Published
- 2025-01-01
- DOI
- https://doi.org/10.7754/clin.lab.2025.250128
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00